DK0929516T3 - Benzamidinderivater og disses anvendelse som lægemidler med LTB4-antagonistisk virkning - Google Patents

Benzamidinderivater og disses anvendelse som lægemidler med LTB4-antagonistisk virkning

Info

Publication number
DK0929516T3
DK0929516T3 DK97942007T DK97942007T DK0929516T3 DK 0929516 T3 DK0929516 T3 DK 0929516T3 DK 97942007 T DK97942007 T DK 97942007T DK 97942007 T DK97942007 T DK 97942007T DK 0929516 T3 DK0929516 T3 DK 0929516T3
Authority
DK
Denmark
Prior art keywords
drugs
antagonistic effect
benzamidine derivatives
ltb4
ltb4 antagonistic
Prior art date
Application number
DK97942007T
Other languages
Danish (da)
English (en)
Inventor
Ralf Anderskewitz
Franz Birke
Hans Michael Jennewein
Christopher John Montagu Meade
Kurt Schromm
Ernst-Otto Renth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0929516T3 publication Critical patent/DK0929516T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DK97942007T 1996-09-10 1997-09-09 Benzamidinderivater og disses anvendelse som lægemidler med LTB4-antagonistisk virkning DK0929516T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19636689A DE19636689A1 (de) 1996-09-10 1996-09-10 Neue Benzamidinderivate
PCT/EP1997/004921 WO1998011062A1 (de) 1996-09-10 1997-09-09 Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung

Publications (1)

Publication Number Publication Date
DK0929516T3 true DK0929516T3 (da) 2003-01-13

Family

ID=7805125

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97942007T DK0929516T3 (da) 1996-09-10 1997-09-09 Benzamidinderivater og disses anvendelse som lægemidler med LTB4-antagonistisk virkning

Country Status (31)

Country Link
US (2) US6197824B1 (ru)
EP (2) EP0929516B1 (ru)
JP (2) JP4150427B2 (ru)
KR (1) KR20000036005A (ru)
CN (1) CN1104412C (ru)
AR (1) AR009741A1 (ru)
AT (2) ATE266630T1 (ru)
AU (1) AU727900B2 (ru)
BG (1) BG63938B1 (ru)
BR (1) BR9712816A (ru)
CA (1) CA2262566C (ru)
CO (1) CO4900032A1 (ru)
CZ (1) CZ297252B6 (ru)
DE (3) DE19636689A1 (ru)
DK (1) DK0929516T3 (ru)
EA (1) EA003245B1 (ru)
EE (1) EE04431B1 (ru)
ES (1) ES2184131T3 (ru)
HK (1) HK1020564A1 (ru)
HU (1) HUP9904367A3 (ru)
IL (1) IL128144A (ru)
NO (1) NO312239B1 (ru)
NZ (1) NZ334895A (ru)
PL (1) PL188012B1 (ru)
PT (1) PT929516E (ru)
SK (1) SK282432B6 (ru)
TR (1) TR199900501T2 (ru)
TW (1) TW378200B (ru)
UA (1) UA60315C2 (ru)
WO (1) WO1998011062A1 (ru)
ZA (1) ZA978045B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29066A (id) 1998-12-14 2001-07-26 Hoffmann La Roche Turunan fenilglisina
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE19948428A1 (de) * 1999-10-07 2001-04-12 Boehringer Ingelheim Pharma Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
DE10052333A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
US6489359B2 (en) 2000-10-24 2002-12-03 Boehringer Ingelheim Pharma Kg Sulphoxybenzamides
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US6608054B2 (en) * 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
NZ530973A (en) * 2001-07-14 2006-07-28 Boehringer Ingelheim Pharma Pharmaceutical formulation containing an LTB4 antagonist
CN1658852A (zh) * 2001-08-31 2005-08-24 神经化学(国际)有限公司 用于治疗淀粉样变性的脒衍生物
DE10213350A1 (de) * 2002-03-26 2003-10-16 Boehringer Ingelheim Pharma Verwendung von LTB¶4¶Antagonisten in der Tiermedizin
US6921752B2 (en) * 2002-03-26 2005-07-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of LTB4 antagonists in veterinary medicine
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CN1997367B (zh) * 2004-07-05 2010-11-24 同和药品株式会社 预防和治疗过敏性炎症的组合物
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
US8679288B2 (en) * 2008-06-09 2014-03-25 Lam Research Corporation Showerhead electrode assemblies for plasma processing apparatuses
CN106831611B (zh) * 2017-01-23 2019-06-21 北京化工大学 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用
EP3623368A4 (en) 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER
WO2020061688A1 (en) * 2018-09-24 2020-04-02 The University Of British Columbia Modulation of granzyme k activity in the treatment of skin conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5246965A (en) 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
PT902013E (pt) 1992-02-05 2002-06-28 Boehringer Ingelheim Pharma Novos derivados amidina sua preparacao e utilizacao como medicamento com actividade antagonista de ltb4
DE4219158A1 (de) * 1992-06-11 1993-12-16 Thomae Gmbh Dr K Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP0929516B1 (de) 2002-09-18
CN1230174A (zh) 1999-09-29
BG103219A (en) 1999-10-29
NO991131D0 (no) 1999-03-09
DE59711625D1 (de) 2004-06-17
HUP9904367A3 (en) 2001-11-28
ATE224363T1 (de) 2002-10-15
CZ297252B6 (cs) 2006-10-11
AU727900B2 (en) 2001-01-04
ZA978045B (en) 1998-03-10
PT929516E (pt) 2003-01-31
JP4150427B2 (ja) 2008-09-17
AU4383897A (en) 1998-04-02
ATE266630T1 (de) 2004-05-15
HUP9904367A2 (hu) 2000-05-28
BR9712816A (pt) 1999-11-23
SK29699A3 (en) 2000-03-13
BG63938B1 (bg) 2003-07-31
EE04431B1 (et) 2005-02-15
EP1203764A1 (de) 2002-05-08
IL128144A (en) 2004-07-25
NO991131L (no) 1999-03-09
PL188012B1 (pl) 2004-11-30
DE59708278D1 (de) 2002-10-24
NZ334895A (en) 2000-09-29
JP2008266333A (ja) 2008-11-06
US6265612B1 (en) 2001-07-24
CO4900032A1 (es) 2000-03-27
NO312239B1 (no) 2002-04-15
KR20000036005A (ko) 2000-06-26
HK1020564A1 (en) 2000-05-12
TW378200B (en) 2000-01-01
CN1104412C (zh) 2003-04-02
EA199900279A1 (ru) 1999-08-26
PL332136A1 (en) 1999-08-30
EA003245B1 (ru) 2003-02-27
WO1998011062A1 (de) 1998-03-19
TR199900501T2 (xx) 1999-07-21
SK282432B6 (sk) 2002-02-05
ES2184131T3 (es) 2003-04-01
JP4288299B2 (ja) 2009-07-01
EP1203764B1 (de) 2004-05-12
DE19636689A1 (de) 1998-03-12
CZ82299A3 (cs) 1999-09-15
US6197824B1 (en) 2001-03-06
IL128144A0 (en) 1999-11-30
EE9900086A (et) 1999-10-15
CA2262566C (en) 2006-07-11
JP2001504087A (ja) 2001-03-27
CA2262566A1 (en) 1998-03-19
EP0929516A1 (de) 1999-07-21
UA60315C2 (ru) 2003-10-15
AR009741A1 (es) 2000-05-03

Similar Documents

Publication Publication Date Title
DK0929516T3 (da) Benzamidinderivater og disses anvendelse som lægemidler med LTB4-antagonistisk virkning
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
HUS1300054I1 (hu) Herbicid hatású 3-hidroxi-4-aril-5-oxo-pirazolin-származékok és alkalmazásuk
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
EE04849B1 (et) Asendatud fenüülderivaadid, nende valmistamine jakasutamine
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
EE200200414A (et) Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO985368D0 (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
FI954491A (fi) Heterosykliä sisältäviä amidiinijohdokset, niiden valmistus ja käyttö
NO955305L (no) Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO950560L (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
EE200200266A (et) 2-arüülkinoliini derivaadid, nende valmistamine ja kasutamine ravimites
NO995966D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse
SI0929516T1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect